Tanya V Kalin

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

EMBO molecular medicine

Nature communications

Nature aging

PLoS genetics

Cincinnati Children's Hospital Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cincinnati Children's Hospital Medical Center

United States

Associate Professor :: Pulmonary Biology

Publications

Fenghua Bian, Chinmayee Goda, Guolun Wang, Ying-Wei Lan, Zicheng Deng, Wen Gao, Anusha Acharya, Abid A Reza, Jose Gomez-Arroyo, Nawal Merjaneh, Xiaomeng Ren, Jermaine Goveia, Peter Carmeliet, Vladimir V Kalinichenko, Tanya V Kalin
FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4. EMBO molecular medicine 16 (5) (2024)
Fenghua Bian, Chinmayee Goda, Guolun Wang, Ying-Wei Lan, Zicheng Deng, Wen Gao, Anusha Acharya, Abid A Reza, Jose Gomez-Arroyo, Nawal Merjaneh, Xiaomeng Ren, Jermaine Goveia, Peter Carmeliet, Vladimir V Kalinichenko, Tanya V Kalin
FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4. EMBO molecular medicine 16 (5) (2024)
Fenghua Bian, Chinmayee Goda, Guolun Wang, Ying-Wei Lan, Zicheng Deng, Wen Gao, Anusha Acharya, Abid A Reza, Jose Gomez-Arroyo, Nawal Merjaneh, Xiaomeng Ren, Jermaine Goveia, Peter Carmeliet, Vladimir V Kalinichenko, Tanya V Kalin
FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4. EMBO molecular medicine 16 (5) (2024)
Fenghua Bian, Chinmayee Goda, Guolun Wang, Ying-Wei Lan, Zicheng Deng, Wen Gao, Anusha Acharya, Abid A Reza, Jose Gomez-Arroyo, Nawal Merjaneh, Xiaomeng Ren, Jermaine Goveia, Peter Carmeliet, Vladimir V Kalinichenko, Tanya V Kalin
FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4. EMBO molecular medicine 16 (5) (2024)
Fenghua Bian, Chinmayee Goda, Guolun Wang, Ying-Wei Lan, Zicheng Deng, Wen Gao, Anusha Acharya, Abid A Reza, Jose Gomez-Arroyo, Nawal Merjaneh, Xiaomeng Ren, Jermaine Goveia, Peter Carmeliet, Vladimir V Kalinichenko, Tanya V Kalin
FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4. EMBO molecular medicine 16 (5) (2024)
Fenghua Bian, Chinmayee Goda, Guolun Wang, Ying-Wei Lan, Zicheng Deng, Wen Gao, Anusha Acharya, Abid A Reza, Jose Gomez-Arroyo, Nawal Merjaneh, Xiaomeng Ren, Jermaine Goveia, Peter Carmeliet, Vladimir V Kalinichenko, Tanya V Kalin
FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4. EMBO molecular medicine (2024)
Fenghua Bian, Ying-Wei Lan, Shuyang Zhao, Zicheng Deng, Samriddhi Shukla, Anusha Acharya, Johnny Donovan, Tien Le, David Milewski, Matthew Bacchetta, Ahmed Emad Hozain, Yuliya Tipograf, Ya-Wen Chen, Yan Xu, Donglu Shi, Vladimir V Kalinichenko, Tanya V Kalin
Lung endothelial cells regulate pulmonary fibrosis through FOXF1/R-Ras signaling. Nature communications 14 (1) (2023)
Fenghua Bian, Ying-Wei Lan, Shuyang Zhao, Zicheng Deng, Samriddhi Shukla, Anusha Acharya, Johnny Donovan, Tien Le, David Milewski, Matthew Bacchetta, Ahmed Emad Hozain, Yuliya Tipograf, Ya-Wen Chen, Yan Xu, Donglu Shi, Vladimir V Kalinichenko, Tanya V Kalin
Lung endothelial cells regulate pulmonary fibrosis through FOXF1/R-Ras signaling. Nature communications 14 (1) (2023)
Fenghua Bian, Ying-Wei Lan, Shuyang Zhao, Zicheng Deng, Samriddhi Shukla, Anusha Acharya, Johnny Donovan, Tien Le, David Milewski, Matthew Bacchetta, Ahmed Emad Hozain, Yuliya Tipograf, Ya-Wen Chen, Yan Xu, Donglu Shi, Vladimir V Kalinichenko, Tanya V Kalin
Lung endothelial cells regulate pulmonary fibrosis through FOXF1/R-Ras signaling. Nature communications 14 (1) (2023)
Fenghua Bian, Ying-Wei Lan, Shuyang Zhao, Zicheng Deng, Samriddhi Shukla, Anusha Acharya, Johnny Donovan, Tien Le, David Milewski, Matthew Bacchetta, Ahmed Emad Hozain, Yuliya Tipograf, Ya-Wen Chen, Yan Xu, Donglu Shi, Vladimir V Kalinichenko, Tanya V Kalin
Lung endothelial cells regulate pulmonary fibrosis through FOXF1/R-Ras signaling. Nature communications 14 (1) (2023)
Rui Ribeiro, Joana C Macedo, Madalena Costa, Vladimir Ustiyan, Anastasia V Shindyapina, Alexander Tyshkovskiy, Rita N Gomes, José Pedro Castro, Tanya V Kalin, Francisco Vasques-Nóvoa, Diana Santos Nascimento, Sergey E Dmitriev, Vadim N Gladyshev, Vladimir V Kalinichenko, Elsa Logarinho
In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan. Nature aging 2 (5) (2022)
Rui Ribeiro, Joana C Macedo, Madalena Costa, Vladimir Ustiyan, Anastasia V Shindyapina, Alexander Tyshkovskiy, Rita N Gomes, José Pedro Castro, Tanya V Kalin, Francisco Vasques-Nóvoa, Diana Santos Nascimento, Sergey E Dmitriev, Vadim N Gladyshev, Vladimir V Kalinichenko, Elsa Logarinho
In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan. Nature aging 2 (5) (2022)
Guolun Wang, Bingqiang Wen, Zicheng Deng, Yufang Zhang, Olena A Kolesnichenko, Vladimir Ustiyan, Arun Pradhan, Tanya V Kalin, Vladimir V Kalinichenko
Endothelial progenitor cells stimulate neonatal lung angiogenesis through FOXF1-mediated activation of BMP9/ACVRL1 signaling. Nature communications 13 (1) (2022)
Rui Ribeiro, Joana C Macedo, Madalena Costa, Vladimir Ustiyan, Anastasia V Shindyapina, Alexander Tyshkovskiy, Rita N Gomes, José Pedro Castro, Tanya V Kalin, Francisco Vasques-Nóvoa, Diana Santos Nascimento, Sergey E Dmitriev, Vadim N Gladyshev, Vladimir V Kalinichenko, Elsa Logarinho
In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan. Nature aging 2 (5) (2022)
Rui Ribeiro, Joana C Macedo, Madalena Costa, Vladimir Ustiyan, Anastasia V Shindyapina, Alexander Tyshkovskiy, Rita N Gomes, José Pedro Castro, Tanya V Kalin, Francisco Vasques-Nóvoa, Diana Santos Nascimento, Sergey E Dmitriev, Vadim N Gladyshev, Vladimir V Kalinichenko, Elsa Logarinho
In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan. Nature aging 2 (5) (2022)
Rui Ribeiro, Joana C Macedo, Madalena Costa, Vladimir Ustiyan, Anastasia V Shindyapina, Alexander Tyshkovskiy, Rita N Gomes, José Pedro Castro, Tanya V Kalin, Francisco Vasques-Nóvoa, Diana Santos Nascimento, Sergey E Dmitriev, Vadim N Gladyshev, Vladimir V Kalinichenko, Elsa Logarinho
In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan. Nature aging 2 (5) (2022)
David Milewski, Samriddhi Shukla, Berkley E Gryder, Arun Pradhan, Johnny Donovan, Parvathi Sudha, Sushmitha Vallabh, Athena Pyros, Yan Xu, Artem Barski, Sara Szabo, Brian Turpin, Joseph G Pressey, Douglas P Millay, Javed Khan, Vladimir V Kalinichenko, Tanya V Kalin
FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma. Oncogene 40 (12) (2021)
Chinmayee Goda, David Balli, Markaisa R Black, David Milewski, Tien Le, Vladimir Ustiyan, Xiaomeng Ren, Vladimir V Kalinichenko, Tanya V Kalin
Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway. PLoS genetics 16 (4) (2020)
David Milewski, David Balli, Vladimir Ustiyan, Tien Le, Hendrik Dienemann, Arne Warth, Kai Breuhahn, Jeffrey A Whitsett, Vladimir V Kalinichenko, Tanya V Kalin
FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas. PLoS genetics 13 (12) (2017)
Lifeng Sun, Xiaomeng Ren, I-Ching Wang, Arun Pradhan, Yufang Zhang, Hannah M Flood, Bo Han, Jeffrey A Whitsett, Tanya V Kalin, Vladimir V Kalinichenko
The FOXM1 inhibitor RCM-1 suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice. Science signaling 10 (475) (2017)

Tanya V Kalin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tanya V Kalin